Filing Details
- Accession Number:
- 0001213900-19-021801
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-01 16:05:36
- Reporting Period:
- 2019-10-31
- Accepted Time:
- 2019-11-01 16:05:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1522602 | Cohbar Inc. | CWBR | Pharmaceutical Preparations (2834) | 261299952 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1627971 | Francis Jeffrey Biunno | C/O Cohbar, Inc. 1455 Adams Drive, Suite 2050 Menlo Park CA 94025 | Cfo, Treasurer And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-10-31 | 5,000 | $0.26 | 15,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-10-31 | 5,000 | $1.95 | 10,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to buy) | Disposition | 2019-10-31 | 5,000 | $0.00 | 5,000 | $0.26 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
359,377 | 2024-04-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,000 | Indirect | By daughter |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- Consists of previously reported shares indirectly beneficially owned by the Reporting Person.
- The options are fully vested.